Cryo-Cell International Inc. (CCEL)

Last Closing Price: 4.65 (2026-10-19)

EBIT Margin (Quarterly)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

Cryo-Cell International Inc. (CCEL) had EBIT Margin of 28.04% for the most recently reported fiscal quarter, ending 2026-08-31.

Figures for fiscal quarter ending 2026-08-31
Income Statement Financials
$7.82M
$1.27M
$1.61M
$6.21M
$5.63M
$2.19M
$-0.37M
$1.83M
$1.76M
$1.27M
$1.27M
$1.27M
$1.18M
$2.19M
$2.53M
8.06M
8.07M
$0.16
$0.16
Balance Sheet Financials
$13.17M
$20.54M
$49.13M
$62.30M
$15.33M
$8.04M
$63.37M
$78.70M
$-16.39M
$-19.17M
$-16.39M
8.06M
Cash Flow Statement Financials
$3.64M
$-0.13M
$-2.41M
$0.32M
$1.43M
$1.11M
--
--
--
Fundamental Metrics & Ratios
0.86
--
--
-0.96
-0.50
79.38%
28.04%
EBIT Margin
28.04%
--
23.33%
16.24%
$3.44M
--
--
--
0.13
3.02
1.14
78.61
-7.75%
-6.63%
2.04%
-15.21%
$-2.03
$0.43
$0.45